Ondřej Slabý (Ondrej Slaby, Manu N Capoor)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Venues

PloS one

Molecular genetics & genomic medicine

Disease markers

The Prostate

This page only lists publications with an associated author ORCID identifier.

Publications

Katerina Slaba, Marta Jezova, Petra Pokorna, Hana Palova, Jana Tuckova, Jan Papez, Dagmar Prochazkova, Petr Jabandziev, Ondřej Slabý
Two sisters with cardiac-urogenital syndrome secondary to pathogenic splicing variant in the MYRF gene with unaffected parents: A case of gonadal mosaicism? Molecular genetics & genomic medicine (2023)
Andrea Stanikova, Martin Jouza, Julia Bohosova, Ondřej Slabý, Petr Jabandžiev
Role of the microbiome in pathophysiology of necrotising enterocolitis in preterm neonates. BMJ paediatrics open 7 (1) (2023)
Jaroslav Juracek, Marie Madrzyk, Michal Stanik, Michaela Ruckova, Karolina Trachtova, Hana Malcikova, Eva Lzicarova, Dominik A Barth, Martin Pichler, Ondřej Slabý
A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer. The Prostate (2022)
Julia Bohosova, Marek Kasik, Adela Kubickova, Karolina Trachtova, Michal Stanik, Alexandr Poprach, Ondřej Slabý
LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro. Journal of clinical laboratory analysis 36 (6) (2022)
Jitka Vaculová, Radek Kroupa, Zdeněk Kala, Jiří Dolina, Tomáš Grolich, Jakub Vlažný, David Said, Lydie Izakovicova Holla, Petra Borilova Linhartova, Vladimír Procházka, Marek Joukal, Petr Jabandžiev, Ondřej Slabý, Lumir Kunovsky
The Use of Confocal Laser Endomicroscopy in Diagnosing Barrett's Esophagus and Esophageal Adenocarcinoma. Diagnostics (Basel, Switzerland) 12 (7) (2022)
Martin Krkoška, Jana Nekvindová, Kateřina Nevědělová, Veronika Zubáňová, Lenka Radová, Jan Vondráček, Jarmila Herůdková, Ondřej Slabý, Igor Kiss, Lucia Bohovicová, Pavel Fabian, Zuzana Tylichová, Zdeněk Kala, Petr Kysela, Lenka Ostřížková, Vladimír Palička, Alena Hyršlová Vaculová
Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma. Pharmacological reports : PR (2021)
Parwez Ahmad, Marek Slavik, Karolina Trachtova, Natalia Anna Gablo, Tomas Kazda, Dominik Gurin, Pavel Smilek, Zuzana Horakova, Bretislav Gal, Marketa Hermanova, Pavel Slampa, Jiri Sana, Ondřej Slabý
Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients. Cellular oncology (Dordrecht) 43 (3) (2020)
Marek Vecera, Jiri Sana, Jan Oppelt, Boris Tichy, Kopkova Alena, Radim Lipina, Martin Smrcka, Radim Jancalek, Marketa Hermanova, Leos Kren, Ondřej Slabý
Testing of library preparation methods for transcriptome sequencing of real life glioblastoma and brain tissue specimens: A comparative study with special focus on long non-coding RNAs. PloS one 14 (2) (2019)
Alena Kopkova, Jiri Sana, Pavel Fadrus, Tana Machackova, Marek Vecera, Vaclav Vybihal, Jaroslav Juracek, Petra Vychytilova-Faltejskova, Martin Smrcka, Ondřej Slabý
MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study. PloS one 13 (12) (2018)
Jaroslav Juracek, Barbora Peltanova, Jan Dolezel, Michal Fedorko, Dalibor Pacik, Lenka Radova, Petra Vesela, Marek Svoboda, Ondřej Slabý, Michal Stanik
Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer. Journal of cellular and molecular medicine 22 (3) (2018)
Marek Slavik, Tetiana Shatokhina, Jiri Sana, Parwez Ahmad, Tomas Kazda, Iveta Selingerova, Marketa Hermanova, Renata Cervena, Tomas Novotny, Petr Burkon, Pavel Smilek, Zuzana Horakova, Pavel Slampa, Ondřej Slabý
Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy. Head & neck 41 (4) (2018)
Ondřej Slabý, Filip Ruzicka, Gurpreet Sandhu, Jess Rollason, Konstantinos Mavrommatis, Fahad S Ahmed, Jonathan E Schmitz, Assaf Raz, Holger Brüggemann, Peter A Lambert, Vincent A Fischetti, Ondrej Slaby
Importance of Propionibacterium acnes hemolytic activity in human intervertebral discs: A microbiological study. PloS one 13 (11) (2018)
Ondřej Slabý, Filip Ruzicka, Jonathan E Schmitz, Garth A James, Tana Machackova, Radim Jancalek, Martin Smrcka, Radim Lipina, Fahad S Ahmed, Todd F Alamin, Neel Anand, John C Baird, Nitin Bhatia, Sibel Demir-Deviren, Robert K Eastlack, Steve Fisher, Steven R Garfin, Jaspaul S Gogia, Ziya L Gokaslan, Calvin C Kuo, Yu-Po Lee, Konstantinos Mavrommatis, Elleni Michu, Hana Noskova, Assaf Raz, Jiri Sana, A Nick Shamie, Philip S Stewart, Jerry L Stonemetz, Jeffrey C Wang, Timothy F Witham, Michael F Coscia, Christof Birkenmaier, Vincent A Fischetti, Ondrej Slaby
Propionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy. PloS one 12 (4) (2017)
Parwez Ahmad, Jiri Sana, Marek Slavik, Pavel Slampa, Pavel Smilek, Ondřej Slabý
MicroRNAs Involvement in Radioresistance of Head and Neck Cancer. Disease markers 2017 (2017)
Petra Vychytilova-Faltejskova, Jana Merhautova, Tana Machackova, Irene Gutierrez-Garcia, José Garcia-Solano, Lenka Radova, Dominika Brchnelova, Katerina Slaba, Marek Svoboda, Jana Halamkova, Regina Demlova, Igor Kiss, Rostislav Vyzula, Pablo Conesa-Zamora, Ondřej Slabý
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. Oncogenesis 6 (11) (2017)

Ondřej Slabý.css-eqlu8i{font-size:small;padding-left:4px;} (Ondrej Slaby, Manu N Capoor)

Publication Activity (10 Years)

Top Topics

Top Venues

Ondřej Slabý (Ondrej Slaby, Manu N Capoor)